Tom is Director at Debiopharm Innovation Fund in Switzerland, focusing on investments in smart data and digital health companies. He also serves on the boards of Immunexpress and Diagnoplex, and previously on GenePOC and Biocartis. Tom has over 25 years of experience in life science commercialization, in both pharmaceuticals and scientific tools. He has held senior roles in Europe and the U.S., including at Molecular Devices Corp, Covalys, Med Discovery, and Debiopharm.
Tom holds a Ph.D. in molecular microbiology from the University of Warwick in the U.K.